Research and Markets: Business Intelligence Report for Wal-Mart Pharmacy

* Reuters is not responsible for the content in this press release.

Thu Oct 23, 2008 10:00am EDT

DUBLIN, Ireland--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/6ea4ab/walmart_pharmacy)
has announced the addition of the "Wal-Mart Pharmacy Business
Intelligence Report 2008" report to their offering.

   Wal-Mart Stores (Wal-Mart) is the worlds largest retailer as
measured by total revenues. At January 31, 2008, Wal-Mart operated 971
discount stores, 2,447 supercenters, 132 Neighborhood Markets and 591
Sam's Clubs in the United States. Internationally, Wal-Mart operates
more than 3,100 stores. Wal-Mart Pharmacy operates nearly 3,500
pharmacies which filled more than 580 million prescriptions in fiscal
2007. Wal-Mart Pharmacys increasing emphasis on includes: plans to
offer pharmacy benefit managements services to employers; $4 generic
drug pricing program; and a co-branded concept called "The Clinic at
Wal-Mart."

   Our BusIntell Report provides the information you need on Wal-Mart
Pharmacy to gain an understanding of what makes the company the
leading mass merchandisers and one of the largest operator of
pharmacies in the world. The BusIntell Report provides the following
sections: Industry Overview/Trends, Company Overview, Corporate
Strategy, Strengths/Weaknesses, Company Executives, Financial
Information, Lines of Business, and Sources.

   Key Topics Covered:

   Retail Pharmacy Overview

   Pharmacy Benefit Management Overview

   Company Overview

   Corporate Strategy

   Strengths/Weaknesses

   Executives

   Financial & Statistical Information

   Lines of Business

   Sources

   For more information visit
http://www.researchandmarkets.com/research/6ea4ab/walmart_pharmacy

Research and Markets
Laura Wood, Senior Manager
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
press@researchandmarkets.com

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.